Genetic determinants of bone mass

被引:37
作者
Baldock, PA
Eisman, JA
机构
[1] Garvan Inst Med Res, Bone & Mineral Res Program, Sydney, NSW 2010, Australia
[2] Univ New S Wales, Sydney, NSW 2010, Australia
关键词
D O I
10.1097/01.moo.0000127828.34643.b4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose of review This review examines recent advances in the analysis of genetic determinants of bone mass. It addresses both human and animal linkage studies as well as genetic manipulations in animals, inbred mouse models, and candidate gene analyses. Recent findings Recent studies have implicated novel regulatory pathways in bone biology including both the neuroendocrine system and metabolic pathways linked to lipid metabolism. Variations in the lipoprotein receptor-related protein 5 (LRP5), part of the Wnt-frizzled pathway, were independently identified by linkage in high and low bone mass families. Subsequently, other high bone mass syndromes have been shown to have mutations in this gene. Neural studies have shown the skeletal regulatory activity of leptin and neuropeptide Y receptors via the hypothalamus. Subsequently, the beta-adrenergic pathway has been implicated, with important changes in bone mass. The lipoxygenase 12/15 pathway, identified through inbred mouse models and through pharmacologic studies with specific inhibitors, has also been shown to have important effects on bone mass. These studies exemplify the value of genetic models both to identify and then confirm pathways by mutational study and pharmacologic interventions. Continuing candidate gene studies often performed with multiple loci complement such discoveries. However, these studies have not focused on the clinical endpoint of fracture and few have included large enough groups to engender confidence in the associations reported, as such studies may require thousands of individuals. Interestingly, results often differ by ethnicity, age, or gender. A small proportion have examined whether relevant genes influence response to treatment. Summary The combinations of human and animal genetic linkage studies have advanced understanding of the regulation of bone mass. Studies ranging from linkage to pharmacology provide optimism for new targets and treatments for osteoporosis.
引用
收藏
页码:450 / 456
页数:7
相关论文
共 73 条
[1]   A common methylenetetrahydrofolate reductase (C677T) polymorphism is associated with low bone mineral density and increased fracture incidence after menopause: Longitudinal data from the Danish osteoporosis prevention study [J].
Abrahamsen, B ;
Madsen, JS ;
Tofteng, CL ;
Stilgren, L ;
Bladbjerg, EM ;
Kristensen, SR ;
Brixen, K ;
Mosekilde, L .
JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 (04) :723-729
[2]   Linkage disequilibrium between polymorphisms in the human TNFRSF1B gene and their association with bone mass in perimenopausal women [J].
Albagha, OME ;
Tasker, PN ;
McGuigan, FEA ;
Reid, DM ;
Ralston, SH .
HUMAN MOLECULAR GENETICS, 2002, 11 (19) :2289-2295
[3]   Hypothalamic Y2 receptors regulate bone formation [J].
Baldock, PA ;
Sainsbury, A ;
Couzens, M ;
Enriquez, RF ;
Thomas, GP ;
Gardiner, EM ;
Herzog, H .
JOURNAL OF CLINICAL INVESTIGATION, 2002, 109 (07) :915-921
[4]   Lack of association between the SOST gene and bone mineral density in perimenopausal women:: Analysis of five polymorphism [J].
Balemans, W ;
Foernzler, D ;
Parsons, C ;
Ebeling, M ;
Thompson, A ;
Reid, DM ;
Lindpaintner, K ;
Ralston, SH ;
Van Hul, W .
BONE, 2002, 31 (04) :515-519
[5]   Genetic variability in adult bone density among inbred strains of mice [J].
Beamer, WG ;
Donahue, LR ;
Rosen, CJ ;
Baylink, DJ .
BONE, 1996, 18 (05) :397-403
[6]   Quantitative trait loci for femoral and lumbar vertebral bone mineral density in C57BL/6J and C3H/HeJ inbred strains of mice [J].
Beamer, WG ;
Shultz, KL ;
Donahue, LR ;
Churchill, GA ;
Sen, S ;
Wergedal, JR ;
Baylink, DJ ;
Rosen, CJ .
JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 (07) :1195-1206
[7]   THE MEDICAL-MANAGEMENT OF PRIMARY HYPERPARATHYROIDISM [J].
BILEZIKIAN, JP .
ANNALS OF INTERNAL MEDICINE, 1982, 96 (02) :198-202
[8]   Association of physical activity and bone:: influence of vitamin D receptor genotype [J].
Blanchet, C ;
Giguère, Y ;
Prud'Homme, D ;
Dumont, M ;
Rousseau, F ;
Dodin, S .
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2002, 34 (01) :24-31
[9]   High bone density due to a mutation in LDL-receptor-related protein 5 [J].
Boyden, LM ;
Mao, JH ;
Belsky, J ;
Mitzner, L ;
Farhi, A ;
Mitnick, MA ;
Wu, DQ ;
Insogna, K ;
Lifton, RP .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (20) :1513-1521
[10]   Relationship among VDR (BsmI and FokI), COLIA1, and CTR polymorphisms with bone mass, bone turnover markers, and sex hormones in men [J].
Braga, V ;
Sangalli, A ;
Malerba, G ;
Mottes, M ;
Mirandola, S ;
Gatti, D ;
Rossini, M ;
Zamboni, M ;
Adami, S .
CALCIFIED TISSUE INTERNATIONAL, 2002, 70 (06) :457-462